Stock to Watch!

Allezoe Medial, ALZM

Allezoe Medical has just launched a new subsidiary - SureScreen Medical - SureScreen will be responsible for taking HPV diagnostic technology through the appropriate trials and federal clearances.

HPV is linked to a number of cancers in both men and women, and it is the most common sexually transmitted infection and most people who become infected are completely unaware of it. Approximately 20 million Americans are infected with HPV — Experts believe that more than 5 million new infections occur each year.

Allezoe – ALZM – recently acquired a company that invented a breakthrough medical technology for the diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer

In addition Allezoe also has a subsidiary - Organ Transport Systems (OTS), a biomedical company developing and commercializing portable hypo-thermic, oxygenated preservation and transport technology for human organs.

The company is aggressively moving toward regulatory approval and commercialization of HPV treatment. It could be very lucrative because of its potential market size and relatively hassle free reimbursement from insurance companies.

The stock hit the bottom under heavy selling pressure and starting to bounce back. The recent acquisition and over sold conditions make it very attractive, short to medium term, very speculative and expect above average volatility.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.